In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...

Researchers have developed technologies that allow damaged proteins to be shredded or healthy ones installed. This may ...

Researchers at National Taiwan University have developed a modular platform to reprogram tumor-derived extracellular vesicles ...

When a drug is injected directly into a tumour, macrophages already present in the body absorb the drug and begin producing ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

The tumor microenvironment (TME) is a metabolically dynamic niche where cancer cells and immune cells interact to influence tumor progression and immune ...

With many more expensive gene therapies on the horizon, the cost of the sickle cell therapies presages financial challenges ...

New melanoma immunotherapy research reveals how changing the way tumors die can awaken immune defenses and improve outcomes in mice.

Researchers have uncovered a stealthy way pancreatic cancer disarms the immune system, using tiny molecular messengers to ...

Cancer represents a key challenge in medical science, manifesting as a disease where the immune system fails to recognize and eliminate tumor cells. The phenomenon of immune evasion by cancer cells ...

T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells.